Lupin informs about press release

15 Sep 2021 Evaluate

Lupin has informed that it attached a press release as regards launch of the authorized generic version of Duexis® (ibuprofen and famotidine) Tablets, 800 mg/ 26.6 mg, of Horizon Medicines LLC. Considered this as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2347.45 15.70 (0.67%)
25-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.85
Dr. Reddys Lab 1301.90
Cipla 1243.90
Zydus Lifesciences 903.60
Lupin 2347.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×